Acamprosate for the adjunctive treatment of alcohol dependence.

Gerald P Overman, Christian J Teter, Sally K Guthrie

Journal: The Annals of pharmacotherapy 2003;37(7-8):1090-9

PMID: 12841823

Abstract

OBJECTIVE

To review the literature related to the treatment of alcohol dependence with acamprosate, a synthetic compound structurally similar to the naturally occurring amino acid, homotaurine.

DATA SOURCES

Primary literature and review articles were identified by MEDLINE search (1966-June 2003). Abstracts from recent meetings were also reviewed.

DATA SYNTHESIS

Acamprosate has been marketed in 24 countries. Although the precise mechanism of acamprosate in the treatment of alcohol-dependent patients is unclear, it may restore the balance between inhibitory and excitatory neurotransmission in the central nervous system. European trials have shown consistent increases in abstinence rates compared with placebo when acamprosate use was paired with appropriate psychosocial and behavioral therapies. Decreased direct and indirect healthcare costs associated with acamprosate treatment have also been reported.

CONCLUSIONS

Acamprosate is a promising medication for the treatment of alcohol dependence in the US.

Address: Clinical Center Pharmacy Department, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892-1196, USA. [email protected]

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.